Rapid molecular detection of rifampicin resistance facilitates early diagnosis and treatment of multi-drug resistant tuberculosis: case control study.
<h4>Background</h4>Multi-drug resistant tuberculosis (MDR-TB) is a major public health concern since diagnosis is often delayed, increasing the risk of spread to the community and health care workers. Treatment is prolonged, and the total cost of treating a single case is high. Diagnosis...
Saved in:
| Main Authors: | Philly O'Riordan, Uli Schwab, Sarah Logan, Graham Cooke, Robert J Wilkinson, Robert N Davidson, Paul Bassett, Robert Wall, Geoffrey Pasvol, Katie L Flanagan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2008-09-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0003173&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Systematic review of the performance of rapid rifampicin resistance testing for drug-resistant tuberculosis.
by: Matthew Arentz, et al.
Published: (2013-01-01) -
Impact of rpoB gene mutations and Rifampicin-resistance levels on treatment outcomes in Rifampicin-resistant tuberculosis
by: Maria Jose Vadakunnel, et al.
Published: (2025-02-01) -
Biological Cost of Helicobacter pylori Rifampicin Resistance
by: K. T. Momynaliev, et al.
Published: (2020-05-01) -
Missed rifampicin and isoniazid resistance by commercial molecular assays
by: L Richards, et al.
Published: (2024-07-01) -
RANGES OF DRUG RESISTANCE OF THE PATHOGEN SENSITIVE TO RIFAMPICIN AND RESISTANT TO ISONIAZID IN PULMONARY TUBERCULOSIS PATIENTS
by: I. A. Burmistrova, et al.
Published: (2019-01-01)